Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.

Sandra GoetzePeter SchüfflerAlcibiade AthanasiouAnika KoetemannCedric PoyetChristian Daniel FankhauserPeter J WildRalph SchiessBernd Wollscheid

Published in: Clinical proteomics (2022)

Using MS-GUIDE we identified fibronectin and vitronectin as candidate biomarkers for prostate cancer risk stratification.

Keyphrases